We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+16.76%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.4B
AUM Growth
-$147M
Cap. Flow
-$283M
Cap. Flow %
-11.81%
Top 10 Hldgs %
28.1%
Holding
209
New
22
Increased
53
Reduced
105
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 29.57%
2 Industrials 16.81%
3 Healthcare 15.75%
4 Financials 10.45%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMVT icon
126
Immunovant
IMVT
$8.24B
$3.7M 0.15%
+149,396
New +$4.24M
NTLA icon
127
Intellia Therapeutics
NTLA
$1.68B
$3.57M 0.15%
306,510
+22,976
+8% +$359K
PTLO icon
128
Portillo's
PTLO
$325M
$3.5M 0.15%
372,745
-739,427
-66% -$8.46M
PDFS icon
129
PDF Solutions
PDFS
$2.01B
$3.5M 0.15%
129,181
-25,690
-17% -$774K
HCAT icon
130
Health Catalyst
HCAT
$129M
$3.49M 0.15%
493,364
-539,119
-52% -$4.29M
HBIO icon
131
Harvard Bioscience
HBIO
$28.8M
$3.41M 0.14%
161,718
-24,825
-13% -$570K
IMNM icon
132
Immunome
IMNM
$2.91B
$3.34M 0.14%
+314,239
New +$3.8M
OSIS icon
133
OSI Systems
OSIS
$3.83B
$3.32M 0.14%
19,851
-13,594
-41% -$2.15M
BLBD icon
134
Blue Bird Corp
BLBD
$2.07B
$3.32M 0.14%
86,006
-55,031
-39% -$2.3M
EXLS icon
135
EXL Service
EXLS
$5.32B
$3.16M 0.13%
71,215
-64,007
-47% -$2.77M
REAX icon
136
Real Brokerage
REAX
$466M
$3.06M 0.13%
664,281
-161,694
-20% -$848K
CSTL icon
137
Castle Biosciences
CSTL
$988M
$2.95M 0.12%
110,824
-314,396
-74% -$9.58M
TSHA icon
138
Taysha Gene Therapies
TSHA
$1.83B
$2.83M 0.12%
1,636,381
+496,482
+44% +$1.03M
URBN icon
139
Urban Outfitters
URBN
$6.81B
$2.78M 0.12%
+50,597
New +$2.16M
CLS icon
140
Celestica
CLS
$39.7B
$2.58M 0.11%
+27,975
New +$2.19M
CERT icon
141
Certara
CERT
$1.23B
$2.55M 0.11%
239,224
-63,257
-21% -$687K
OLLI icon
142
Ollie's Bargain Outlet
OLLI
$4.8B
$2.45M 0.1%
+22,322
New +$2.22M
FOXF icon
143
Fox Factory Holding Corp
FOXF
$884M
$2.4M 0.1%
79,417
-138,768
-64% -$4.78M
SMMT icon
144
Summit Therapeutics
SMMT
$11.9B
$2.39M 0.1%
133,832
+7,734
+6% +$150K
AVPT icon
145
AvePoint
AVPT
$2.75B
$2.27M 0.09%
137,306
-35,705
-21% -$542K
VICR icon
146
Vicor
VICR
$9.63B
$2.11M 0.09%
43,760
-4,758
-10% -$238K
SKX
147
DELISTED
Skechers
SKX
$2.1M 0.09%
31,241
-125,521
-80% -$8.14M
RXO icon
148
RXO
RXO
$3.52B
$2.08M 0.09%
+87,251
New +$2.44M
VCYT icon
149
Veracyte
VCYT
$3.72B
$1.96M 0.08%
49,515
-262,466
-84% -$9.94M
HASI icon
150
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.21B
$1.89M 0.08%
70,582
-3,986
-5% -$125K

Similar funds

Granahan Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Granahan Investment Management held 209 positions worth $2.4B, down 5.8% from $2.54B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Granahan Investment Management withdrew a net $283M in Q4 2024, closing 29 positions and reducing 105 holdings. Its most notable exit was Smartsheet Inc., an estimated $33.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Granahan Investment Management opened a new position in KinderCare Learning Companies worth $25.7M.

  • Granahan Investment Management's largest Q4 2024 buy was KinderCare Learning Companies: 1,446,059 shares worth $25.7M.
  • Granahan Investment Management added most to Marex Group Limited Ordinary Shares in Q4 2024, an estimated $26.8M increase.
  • Granahan Investment Management's biggest Q4 2024 reduction was Zeta Global, cutting an estimated $55.8M.
  • Granahan Investment Management fully exited Smartsheet Inc. in Q4 2024, selling an estimated $33.3M.
  • Granahan Investment Management's ten largest holdings make up 28% of its $2.4B portfolio in Q4 2024.
  • Granahan Investment Management opened 22 new positions and closed 29 in Q4 2024.
  • Granahan Investment Management's portfolio value fell 5.8% quarter-over-quarter to $2.4B.

Based on Granahan Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.